EUVIMEDEUVIMED entdecken
Open Access · CC BY-SA 4.0

QSAR treatment of meisoindigo derivatives as a potentbreast anticancer agent

Evie Kama Lestari, Agus Dwi Ananto, Maulida Septiyana, Saprizal Hadisaputra

Acta Chimica Asiana · 2019

DOI: 10.29303/aca.v2i2.12 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Chimica Asiana, 2019. Verfasst von Evie Kama Lestari und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A quantitative structure-activity relationship (QSAR) analysis of meisoindigo derivatives as a breast anticancer has been carried out. This study aimed to obtain the best QSAR model in order to design new meisoindigo based compounds with best anticancer activity. The semiempirical PM3 method was used for descriptor calculation. The best QSAR model was built using multilinear regression (MLR) with enter method. It was found that there were 19 new meisoindigo derivativeswith better predictive a potent anticancer agent. The best compound was (E)-2-(1-((3-ethylisoxazol-5-yl)methyl)-2-oxoindolin-3-ylidene)-N-(4-methoxyphenyl)acetamide with the value of IC505.31144 x10-15 (μM).

Zitieren

APA

Lestari, E. K., Ananto, A. D., Septiyana, M., & Hadisaputra, S. (2019). QSAR treatment of meisoindigo derivatives as a potentbreast anticancer agent. Acta Chimica Asiana. https://doi.org/10.29303/aca.v2i2.12

Vancouver

Lestari EK, Ananto AD, Septiyana M, Hadisaputra S. QSAR treatment of meisoindigo derivatives as a potentbreast anticancer agent. Acta Chimica Asiana. 2019. doi:10.29303/aca.v2i2.12

BibTeX
@article{Lestari2019,
  author = {Lestari, Evie Kama and Ananto, Agus Dwi and Septiyana, Maulida and Hadisaputra, Saprizal},
  title = {QSAR treatment of meisoindigo derivatives as a potentbreast anticancer agent},
  journal = {Acta Chimica Asiana},
  year = {2019},
  doi = {10.29303/aca.v2i2.12}
}
Kostenlos starten →